The internalized CdSe/ZnS quantum dots impair the chondrogenesis of bone marrow mesenchymal stem cells

Shu-Chen Hsieh1, Fung-Fang Wang, Shih-Chieh Hung

  • 1Institute of Biomedical Engineering, National Yang Ming University, Shih-Pai, Taipei, Taiwan, Republic of China.

Insights

Quantum dots (QDs) labeling human mesenchymal stem cells (MSCs) did not affect cell proliferation but impaired chondrogenic differentiation. This suggests caution when using QDs for tracking stem cells in therapeutic applications.

Area of Science:

  • Biomedical Engineering
  • Stem Cell Biology
  • Nanotechnology

Background:

  • Mesenchymal stem cells (MSCs) are crucial for regenerative medicine due to their differentiation potential.
  • Fluorescent labeling of MSCs aids in tracking their behavior post-transplantation.
  • Quantum dots (QDs) offer bright and stable fluorescence for cellular imaging.

Purpose of the Study:

  • To investigate the impact of CdSe/ZnS quantum dots (QDs) on human bone marrow MSCs.
  • To assess the effects of QD labeling on MSC proliferation and chondrogenesis.

Main Methods:

  • Human bone marrow MSCs were labeled with CdSe/ZnS QDs.
  • Cell proliferation assays were performed.
  • Chondrogenesis induction was carried out, followed by analysis of chondrosphere formation.
  • Gene and protein expression of chondrogenic markers (collagen type II, aggrecan) were evaluated.

Main Results:

  • QDs localized to the perinuclear region and were stable through multiple cell passages.
  • QD labeling did not significantly alter MSC proliferation rates.
  • Chondrosphere size remained unaffected by QD presence.
  • Significant inhibition of type II collagen and aggrecan mRNA and protein expression was observed in QD-labeled MSCs undergoing chondrogenesis.

Conclusions:

  • CdSe/ZnS QDs interfere with the chondrogenic differentiation of human MSCs.
  • The use of QDs as fluorescence tracers for stem cell applications requires careful consideration due to potential impacts on differentiation pathways.